Fixed Drug Eruption to Paracetamol in a Child
Sir, Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the development of erythematous itchy or asymptomatic macules caused by intake of a variety of drugs. We hereby like to describe a case of FDE due to paracetamol in a 9-year-old child. Paracetamol also known as acetaminophen belongs to the para-aminophenol group of nonsteroidal anti-inflammatory drugs (NSAIDs). It is widely used as antipyretic and analgesic with a great safety profile in children and adults. Cutaneous reactions to acetaminophen are not very common and usually are idiosyncratic and include anaphylaxis, urticaria, a widespread maculopapular eruption, and rarely FDE. [1] A 9-year-old healthy female child presented with multiple blackish discoloration of skin on eyes and trunk from the past 2 weeks. She had a history of fever 3 weeks back, for which she had received paracetamol. There was no history of any other drug intake. A day after taking paracetamol, she developed reddish lesions initially around the eyes and trunk which resolved with mild hyperpigmentation. History of a similar episode of skin lesion was present on the same site 2 years back with intake of paracetamol. Hence, the patient was on mefenamic acid for episodes of fever for 2 years. On examination, the child had few well-defined discrete, hyperpigmented macules surrounded by a rim of erythema on the back and periocular area [ Figures 1 and 2 ]. Systemic examination was normal. Complete hemogram and biochemistry profile was normal. Skin biopsy was not done as the parents did not give consent. Given the history of recurrent lesions occurring at the same site after ingestion of paracetamol and clinical presentation diagnosis of FDE due to paracetamol was considered. Oral provocation test was not done as parents did not give consent.
The term FDE was introduced by Brocq in 1894. [2] FDE presents as sharply marginated, round, erythematous to violaceous, plaques occurring after the ingestion of a drug. [2] They may be solitary, multiple, or generalized. The initial eruption of an FDE appears 1-week postdrug exposure, whereas subsequent exposures to the same drug lead to the development of lesions within 30 min to 24 h. Despite the number of occurrences, these patches and plaques resolve within 2-3 weeks of discontinuing the offending agent, often leaving postinflammatory hyperpigmentation. [3] Apart from the classical FDE, generalized, bullous, extensive bilateral symmetrical, pulsating, wandering, and nonpigmenting types have been reported. [4] FDE may occur on any part of the skin and mucous membranes, including the transitional epithelium of the mucocutaneous junctions. The sites of predilection include lips, hands, feet, genitalia, and perianal area, but the distribution of lesions seems to be influenced by the type of drug is questionable. [5] Literature review has shown paracetamol-indued FDE is most commonly on the trunk and limbs. [5] FDE is the second most common type of drug eruption in children. [6] The most common drug known to cause FDE in children is combination drug trimethoprim-sulfamethoxazole. [2, 7] Other drugs known to cause FDE in children are antibiotics such as tetracycline, amoxicillin, ampicillin, and erythromycin, NSAIDs such as ibuprofen, paracetamol, diclofenac, and ketorolac, phenobarbital, hydroxyzine, phenolphthalein, and temazepam. [6] FDE to paracetamol is rare in children. Approximately 21 cases of FDE to paracetamol in children are reported in literature. Most common type of FDE reported was the classical type. Bullous FDE to paracetamol is extremely rare, and only two cases are reported so far. Paracetamol is the most common drug prescribed in children and considered to be the most safe medication. Pediatricians and dermatologists must be aware of the reactions caused by paracetamol as it can be easily missed as the culprit. Knowledge about the cutaneous adverse reactions caused by paracetamol can prevent recurrent episodes and complications in children.
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